摘要
目的:研究雌激素促进人的类成骨细胞株TE85细胞骨形成的作用。方法:用3H胸腺嘧啶、3H脯氨酸参入法分别测定细胞的增殖和胶原合成;紫外分光光度法测定细胞内骨碱性磷酸酶(ALP)活性;放免法测定细胞内骨钙素(BGP)含量;放射配基法测定细胞核雌激素受体结合。结果:雌激素(E2,001~10nmol·L-1)可浓度依赖地刺激TE85细胞的3H胸腺嘧啶和3H脯氨酸的参入量;在相同的时间点和剂量下,可增加成骨细胞内ALP活性和BGP的含量。结论:E2通过增加成骨细胞数量、促进细胞胶原蛋白及ALP和BGP的合成而促进成骨作用,这些作用是通过雌激素受体介导的。
AIM: To study the effects of estrogen on stimulating bone formation in osteoblast like cell line TE85. METHODS: Utilizing methods of 3H thymidine incorporation for cell proliferation, 3H proline incorporation for collagen synthesis, ultraviolet spectrophotometry for measurement of alkaline phosphatase (ALP) activity, radioimmunoassay for bone gla protein (BGP) content assay, and radio ligand binding for estrogen receptor assay. RESULTS: Cells were incubated with various concentrations (from 0 01 to 10 nmol·L -1 ) of 17β estradiol (E 2) for 48 h and 72 h, 3H thymidine incorporation into DNA was increased gradually while 3H proline incorporation was enhanced in the same fashion. E 2 at the same dose increased the intracellular ALP activity and BGP content at the same time. In ligand receptor binding experiment, the K D of 3H E 2 saturation test was 2 59×10 -10 mol·L -1 in TE85 cells and the receptor number was found to be 262 7±64 6 site per cell. The IC 50 of 4 OH tamoxifen and ICI 182,780 were 0 99×10 -8 mol·L -1 and 8×10 -10 mol·L -1 , respectively. CONCLUSION: E 2 improved bone formation by ways of stimulating cell proliferation, enhancing collagen synthesis, ALP activity, and BGP content. The effects of E 2 were performed by the mediation of estrogen receptor.
出处
《药学学报》
CAS
CSCD
北大核心
1999年第8期561-564,共4页
Acta Pharmaceutica Sinica
基金
国家自然科学基金